A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Taiho Oncology, Inc.
Taiho Oncology, Inc.
Blueprint Medicines Corporation
Cancer Research UK
M.D. Anderson Cancer Center
Geron Corporation
Cancer Research UK
Ann & Robert H Lurie Children's Hospital of Chicago
National Cancer Institute (NCI)
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Swedish Orphan Biovitrum
Bellicum Pharmaceuticals
M.D. Anderson Cancer Center
Gruppo Italiano Trapianto di Midollo Osseo
Swedish Orphan Biovitrum
The First Affiliated Hospital of Soochow University
Roswell Park Cancer Institute
Kiadis Pharma
St. Anna Kinderkrebsforschung
Cardiff University
M.D. Anderson Cancer Center
Novartis
Hoffmann-La Roche
Charite University, Berlin, Germany
Hospital Virgen de la Salud
Bristol-Myers Squibb
University of Zurich
Gamida Cell -Teva Joint Venture Ltd.
Amneal Pharmaceuticals, LLC
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Tehran University of Medical Sciences
Virginia Commonwealth University
Rambam Health Care Campus
Royal Marsden NHS Foundation Trust